Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2026)

Maravai Lifesciences Holdings (MRVI) recorded quarterly Other Non Operating Income of -$494000.0 in Q1 2026, down 1048.84% quarter-over-quarter from -$43000.0 in Q4 2025, and down 2158.33% on a YoY basis from $24000.0 in Q1 2025.

Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2026) Analysis & Trends

Maravai Lifesciences Holdings' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$494000.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income fell 2158.33% year-over-year to -$494000.0; the TTM figure through Mar 2026 stood at -$4.7 million (down 42.86% YoY), while the FY2025 annual figure was -$4.2 million, down 30.28% from the prior year.
  • Other Non Operating Income was -$494000.0 for Q1 2026 at Maravai Lifesciences Holdings, down from -$43000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q4 2023 to a low of -$4.1 million in Q2 2025.
  • Historically, Other Non Operating Income has averaged -$515250.0 across 5 years, with a median of -$57000.0 in 2025.
  • Biggest YoY gain for Other Non Operating Income was 1464.1% in 2022; the steepest drop was 42400.0% in 2022.
  • A 5-year view of Other Non Operating Income shows it stood at $1.1 million in 2022, then surged by 30.26% to $1.4 million in 2023, then slumped by 157.94% to -$803000.0 in 2024, then jumped by 94.65% to -$43000.0 in 2025, then plunged by 1048.84% to -$494000.0 in 2026.
  • The last three Other Non Operating Income figures came in at -$494000.0 (Q1 2026), -$43000.0 (Q4 2025), and -$71000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Maravai Lifesciences Holdings 747.50 Mn 739.10 Mn 33.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -494,000.00
Dec 31, 2025 -43,000.00
Sep 30, 2025 -71,000.00
Jun 30, 2025 -4.06 Mn
Mar 31, 2025 24,000.00
Dec 31, 2024 -803,000.00
Sep 30, 2024 72,000.00
Jun 30, 2024 -2.56 Mn
Mar 31, 2024 106,000.00
Dec 31, 2023 1.39 Mn
Sep 30, 2023 66,000.00
Jun 30, 2023 -1.62 Mn
Mar 31, 2023 168,000.00
Dec 31, 2022 1.06 Mn
Jun 30, 2022 -1.28 Mn
Mar 31, 2022 -200,000.00
Dec 31, 2021 -78,000.00
Sep 30, 2021 78,000.00
Jun 30, 2021 -3,000.00
Mar 31, 2021 3,000.00